Globe Life Inc SEC Filings

Globe Life Inc. (GL) furnished an 8-K announcing its third quarter 2025 results. The company issued a press release on October 22, 2025, and attached it as Exhibit 99.1.

The disclosure under Item 2.02 (Results of Operations and Financial Condition) is provided pursuant to General Instruction B.2 and is deemed “furnished,” not “filed” under the Exchange Act, which limits its incorporation into other filings absent specific reference.

The filing also lists Exhibit 104 (Cover Page Interactive Data File). No specific financial figures are included in this report; details reside in the press release.

Dolores L. Skarjune, EVP and Chief Administrative Officer of Globe Life Inc. (GL), reported option exercises and a sale on 09/12/2025. She exercised options to acquire 2,100 shares at $82.56 and 2,400 shares at $98.32, and sold 4,500 shares at $142.52. Following these transactions she directly beneficially owns 9,417 shares and indirectly holds 2,701.527 shares through a 401(k) plan, for a combined reported position of 13,917 shares.

Form 144 filed for Globe Life Inc. (GL) reports an intended sale of 4,500 shares of common stock through APEX CLEARING on the NYSE with an aggregate market value of $641,205 and an approximate sale date of 09/12/2025. The shares were acquired by the seller from Globe Life via stock option exercises on 02/28/2019 (2,100 shares) and 02/24/2021 (2,400 shares); the payment source for the sale is listed as proceeds of stock option exercise. The filing also discloses a sale on 09/10/2025 of 4,974 shares generating gross proceeds of $695,532.32. The filer attests not to possess undisclosed material adverse information.

Dolores L. Skarjune, Executive Vice President and Chief Administrative Officer of Globe Life Inc. (GL), reported multiple transactions dated 09/10/2025. She exercised an employee stock option to acquire 6,200 shares at an exercise price of $103.23 per share. On the same date she sold 3,354 shares at prices ranging from $139.31 to $140.01 and sold an additional 1,620 shares at prices ranging from $140.015 to $140.49. After these transactions she beneficially owned 11,037 shares directly and 2,701.527 shares indirectly through a 401(k) plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.

Globe Life Inc. Form 144 filing for proposed sale of common stock. The notice reports an intended sale of 6,200 shares of Globe Life common stock through APEX CLEARING on the NYSE with an aggregate market value of $870,852 and approximately 80,432,773 shares outstanding. The shares were acquired on 02/23/2022 via a stock option exercise from Globe Life Inc., and the proposed sale date is 09/10/2025. The filer states there were no sales by the same person in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.

This Form 3 reports that Robert Sweeney, listed at the provided McKinney, TX address, filed an initial beneficial ownership statement for Globe Life Inc. (GL) related to a 07/28/2025 event. Mr. Sweeney is identified as an officer (EVP, Underwriting & Sales Adm.). The filing discloses zero shares of Globe Life common stock held directly or indirectly and references a 401(k) plan. The form is signed by an attorney-in-fact on behalf of Robert Sweeney.

Globe Life Inc. (GL) filed its Q2-25 Form 10-Q. Total assets rose 2.5% since YE-24 to $29.8 bn, driven by a $353 mm increase in invested assets to $19.9 bn and a $259 mm build in deferred acquisition costs. Shareholders’ equity improved to $5.42 bn from $5.31 bn as retained earnings increased $451 mm to $8.45 bn, partially offset by additional share repurchases (treasury stock up $394 mm, 16.2 mm shares held).

Policy liabilities grew 2.2% to $20.14 bn, with future policy benefits accounting for $18.85 bn. Debt remained essentially flat at $2.79 bn (short- and long-term combined), while the company’s cash position strengthened to $239 mm versus $165 mm at YE-24.

On the income side, premium revenue advanced 4.3% YoY to $1.22 bn for the quarter and 4.5% to $2.42 bn year-to-date. Net investment income ticked down 1.2% to $282 mm, and realized losses widened to $18.6 mm versus $12.6 mm a year earlier. Further earnings data were not provided in the excerpt. Common shares outstanding on 31 Jul 25 were 81.0 mm.

Globe Life Inc. (GL) – Form 4 insider activity

On 08/01/2025, EVP & Chief Strategy Officer Michael C. Majors exercised 10,000 employee stock options at an exercise price of $100.74. The newly issued shares were almost entirely sold the same day:

• Sales of 9,991 and 9 shares occurred within a $136.79–$137.78 range; weighted average disclosed at $137.41.
• Approximate gross proceeds: $1.37 million; option cost: $1.01 million.
• After the transactions, Majors holds 47,066 common shares directly, unchanged versus pre-exercise level.
• He retains 27,000 stock options (right to buy) expiring 02/26/2027.

No other equity or derivative movements were reported. The filing reflects a routine option exercise-and-sell transaction rather than an outright open-market purchase or disposal.